Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Core Viewpoint - Investors with significant losses in Hims & Hers Health, Inc. have the opportunity to lead a securities fraud class action lawsuit against the company [1]. Group 1: Lawsuit Details - The lawsuit alleges that between April 29, 2025, and June 23, 2025, Hims failed to disclose that it was involved in the deceptive promotion and sale of illegitimate versions of Wegovy, which posed risks to patient safety [3]. - The complaint also claims that there was a substantial risk of termination of Hims' collaboration with Novo Nordisk due to these undisclosed actions [3]. - As a result of the aforementioned issues, the positive statements made by Hims regarding its business operations and prospects were materially misleading and lacked a reasonable basis [3]. Group 2: Participation Information - Investors who suffered losses in Hims & Hers Health, Inc. are encouraged to contact the Law Offices of Howard G. Smith before August 25, 2025, to participate in the ongoing lawsuit [2]. - Interested parties can reach out via email or phone to discuss their legal rights and options regarding the class action [4].